These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18627279)

  • 1. A qualitative examination of the indirect effects of modified directly observed therapy on health behaviors other than adherence.
    Bradley-Ewing A; Thomson D; Pinkston M; Goggin KJ
    AIDS Patient Care STDS; 2008 Aug; 22(8):663-8. PubMed ID: 18627279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence among women with HIV infection in Puerto Rico: the potential use of modified directly observed therapy (MDOT) among pregnant and postpartum women.
    Ciambrone D; Loewenthal HG; Bazerman LB; Zorilla C; Urbina B; Mitty JA
    Women Health; 2006; 44(4):61-77. PubMed ID: 17456464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation.
    Pearson CR; Micek M; Simoni JM; Matediana E; Martin DP; Gloyd S
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1(Suppl 1):S134-41. PubMed ID: 17133197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users.
    Macalino GE; Hogan JW; Mitty JA; Bazerman LB; Delong AK; Loewenthal H; Caliendo AM; Flanigan TP
    AIDS; 2007 Jul; 21(11):1473-7. PubMed ID: 17589194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The feasibility of modified directly observed therapy for HIV-seropositive African American substance users.
    Ma M; Brown BR; Coleman M; Kibler JL; Loewenthal H; Mitty JA
    AIDS Patient Care STDS; 2008 Feb; 22(2):139-46. PubMed ID: 18260805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified directly observed therapy for antiretroviral therapy: a primer from the field.
    Goggin K; Liston RJ; Mitty JA
    Public Health Rep; 2007; 122(4):472-81. PubMed ID: 17639650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial examining the efficacy of motivational counseling with observed therapy for antiretroviral therapy adherence.
    Goggin K; Gerkovich MM; Williams KB; Banderas JW; Catley D; Berkley-Patton J; Wagner GJ; Stanford J; Neville S; Kumar VK; Bamberger DM; Clough LA
    AIDS Behav; 2013 Jul; 17(6):1992-2001. PubMed ID: 23568228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the impact of modified directly observed antiretroviral therapy on HIV suppression and resistance, disease progression, and death.
    Kagay CR; Porco TC; Liechty CA; Charlebois E; Clark R; Guzman D; Moss AR; Bangsberg DR
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S414-20. PubMed ID: 15156432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An empirical test of the information-motivation-behavioral skills model of ART adherence in a sample of HIV-positive persons primarily in out-of-HIV-care settings.
    Horvath KJ; Smolenski D; Amico KR
    AIDS Care; 2014 Feb; 26(2):142-51. PubMed ID: 23724908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Information and Motivation and Behavioral Skills Model of ART Adherence among HIV-Positive Adults in Mexico.
    Santillán Torres Torija C; Villagrán Vázquez G; Robles Montijo SS; de Lourdes Eguiluz Romo L
    J Int Assoc Provid AIDS Care; 2015; 14(4):335-42. PubMed ID: 25979257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a directly observed therapy adherence intervention for adolescents with human immunodeficiency virus-1: application of focus group methodology to inform design, feasibility, and acceptability.
    Garvie PA; Lawford J; Flynn PM; Gaur AH; Belzer M; McSherry GD; Hu C;
    J Adolesc Health; 2009 Feb; 44(2):124-132. PubMed ID: 19167660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of community-based modified directly observed therapy for the treatment of HIV-infected persons.
    Mitty JA; Macalino GE; Bazerman LB; Loewenthal HG; Hogan JW; MacLeod CJ; Flanigan TP
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):545-50. PubMed ID: 16044005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.
    Wohl AR; Garland WH; Valencia R; Squires K; Witt MD; Kovacs A; Larsen R; Hader S; Anthony MN; Weidle PJ
    Clin Infect Dis; 2006 Jun; 42(11):1619-27. PubMed ID: 16652320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: the healthy living project randomized controlled study.
    Johnson MO; Charlebois E; Morin SF; Remien RH; Chesney MA;
    J Acquir Immune Defic Syndr; 2007 Dec; 46(5):574-80. PubMed ID: 18193499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique.
    Pearson CR; Micek MA; Simoni JM; Hoff PD; Matediana E; Martin DP; Gloyd SS
    J Acquir Immune Defic Syndr; 2007 Oct; 46(2):238-44. PubMed ID: 17693890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of engagement in HIV treatment and care among Zambians new to antiretroviral therapy.
    Jones DL; Zulu I; Vamos S; Cook R; Chitalu N; Weiss SM
    J Assoc Nurses AIDS Care; 2013; 24(5):e1-12. PubMed ID: 23009738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The information-motivation-behavioral skills model of antiretroviral adherence and its applications.
    Fisher JD; Amico KR; Fisher WA; Harman JJ
    Curr HIV/AIDS Rep; 2008 Nov; 5(4):193-203. PubMed ID: 18838059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an intervention addressing information, motivation, and behavioral skills on HIV care adherence in a southern clinic cohort.
    Konkle-Parker DJ; Amico KR; McKinney VE
    AIDS Care; 2014; 26(6):674-83. PubMed ID: 24116922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial.
    Parsons JT; Golub SA; Rosof E; Holder C
    J Acquir Immune Defic Syndr; 2007 Dec; 46(4):443-50. PubMed ID: 18077833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
    Stone VE; Jordan J; Tolson J; Miller R; Pilon T
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):808-16. PubMed ID: 15213564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.